Screening for fetal anomalies by ultrasound at 14 and 21 weeks

Ultrasound Obstet Gynecol. 1997 Dec;10(6):375-80. doi: 10.1046/j.1469-0705.1997.10060375.x.

Abstract

A prospective study of screening for fetal abnormalities and chromosomal defects was carried out by ultrasound examination at 13-15 weeks of gestation and 20-22 weeks; the first scan was performed transvaginally and the second transabdominally. During a 4-year period (1991-95), 3490 unselected consecutive pregnancies with a total of 3514 fetuses were examined. There were 21 chromosomally abnormal fetuses, including ten with trisomy 21, and, in 19 (90.5%), fetal defects were detected at the first and/or second ultrasound examination. The most effective marker for chromosomal defects was increased nuchal translucency thickness (> or = 4 mm) at the 13-15-week scan, which was present in seven of the ten fetuses with trisomy 21 and in six of the 11 with other chromosomal abnormalities.

MeSH terms

  • Adult
  • Chromosome Aberrations / classification
  • Chromosome Aberrations / diagnostic imaging*
  • Chromosome Disorders
  • Chromosomes, Human / genetics
  • Endosonography
  • Female
  • Fetal Diseases / diagnostic imaging*
  • Fetal Diseases / genetics
  • Fetus / abnormalities*
  • Gestational Age
  • Humans
  • Karyotyping
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity
  • Ultrasonography, Prenatal*